A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Clinical trial NCT03733990 · COMPLETED
Trial details
- NCT number
- NCT03733990
- Sponsor
- Faron Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2023-09-06
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.